- Home
- IQV vs CVNA Comparison
IQV vs CVNA Comparison
Compare IQV & CVNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IQV
- CVNA
- Stock Information
- Founded
- IQV 1982
- CVNA 2012
- Country
- IQV United States
- CVNA United States
- Employees
- IQV N/A
- CVNA N/A
- Industry
- IQV Biotechnology: Commercial Physical & Biological Resarch
- CVNA Other Specialty Stores
- Sector
- IQV Health Care
- CVNA Consumer Discretionary
- Exchange
- IQV Nasdaq
- CVNA Nasdaq
- Market Cap
- IQV 35.7B
- CVNA 28.6B
- IPO Year
- IQV 2013
- CVNA 2017
- Fundamental
- Price
- IQV $200.02
- CVNA $257.34
- Analyst Decision
- IQV Strong Buy
- CVNA Buy
- Analyst Count
- IQV 17
- CVNA 20
- Target Price
- IQV $254.50
- CVNA $245.17
- AVG Volume (30 Days)
- IQV 1.4M
- CVNA 4.0M
- Earning Date
- IQV 02-06-2025
- CVNA 02-19-2025
- Dividend Yield
- IQV N/A
- CVNA N/A
- EPS Growth
- IQV 27.98
- CVNA N/A
- EPS
- IQV 7.62
- CVNA N/A
- Revenue
- IQV $15,315,000,000.00
- CVNA $12,550,000,000.00
- Revenue This Year
- IQV $3.67
- CVNA $27.38
- Revenue Next Year
- IQV $4.40
- CVNA $17.29
- P/E Ratio
- IQV $26.13
- CVNA N/A
- Revenue Growth
- IQV 3.10
- CVNA 12.21
- 52 Week Low
- IQV $187.62
- CVNA $43.87
- 52 Week High
- IQV $261.73
- CVNA $268.34
- Technical
- Relative Strength Index (RSI)
- IQV 47.86
- CVNA 69.14
- Support Level
- IQV $195.99
- CVNA $240.97
- Resistance Level
- IQV $204.10
- CVNA $255.99
- Average True Range (ATR)
- IQV 4.78
- CVNA 10.95
- MACD
- IQV -0.26
- CVNA 3.86
- Stochastic Oscillator
- IQV 40.84
- CVNA 96.37
About IQV IQVIA Holdings Inc.
IQVIA is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.
About CVNA Carvana Co.
Carvana Co is an e-commerce platform for buying and selling used cars. The company derives revenue from used vehicle sales, wholesale vehicle sales and other sales and revenues. The other sales and revenues include sales of loans originated and sold in securitization transactions or to financing partners, commissions received on VSCs and sales of GAP waiver coverage. The foundation of the business is retail vehicle unit sales. This drives the majority of the revenue and allows the company to capture additional revenue streams associated with financing, VSCs, auto insurance and GAP waiver coverage, as well as trade-in vehicles.